Skip to main content

Addiction Treatment Market is estimated to Witness High Growth Owing to Rising Drug Abuse and Addiction Cases

Addiction Treatment Market

The addiction treatment market involves treating substance or process addictions through medication, therapy, or counseling. Some common addictions treated include alcohol, tobacco, opioid, cannabis, and other drug addictions. The increasing availability and social acceptability of addictive substances has fueled a rise in substance abuse disorders globally. As per the National Survey on Drug Use and Health, 20.3 million American adults battled a substance use disorder in 2019. Addiction not only severely impacts physical and mental health but also places a massive economic burden on societies. This growing addiction crisis is expected to drive greater demand for effective treatment and rehabilitation programs.

The global addiction treatment market is estimated to be valued at US$ 16.6 billion in 2024 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the addiction treatment market are Indivior, Pfizer, Alkermes, Novartis, and Mylan.

Some key opportunities in the market include the entry of new targeted therapies expanding treatment options, growing awareness campaigns reducing stigma and improving treatment seeking behavior, and greater public funding supporting widespread availability of affordable care.

Geographically, North America dominates the addiction treatment market currently. However, regions such as Asia Pacific and Latin America are expected to offer lucrative expansion opportunities owing to improving healthcare infrastructure and increasing prioritization of addiction disorders.

Market Drivers

The growing opioid epidemic and rising social acceptance of substance use are major Addiction Treatment Market Demand expanding the patient population and treatment needs. According to the WHO, around 275 million people worldwide used drugs at least once during 2019. Easy availability of illicit substances online and through trafficking is worsening the problem.

Higher treatment success rates associated with newer therapies compared to conventional options is another key factor positively impacting the market. Improved formulations allowing monthly or quarterly dosing improve medication adherence critical for effective treatment. Widening insurance coverage for substance abuse disorders in various countries is also propelling market revenues by improving access and affordability.

PEST Analysis

Political: The political environment plays a key role in healthcare policies, insurance regulations, and funding for addiction treatment programs. Stringent regulations regarding access and quality of treatment services impact the market growth.

Economic: Economic factors such as recession, unemployment rate, and income levels determine the affordability of treatment services. Rise in healthcare spending boosts the market demand.

Social: Social stigmas associated with addiction disorders are reducing with growing awareness. Support groups and non-profits advocating treatment positively influence the social environment.

Technological: Digital technologies help in remote monitoring, therapeutic interventions, and relapse prevention. Wearables, smartphones, telehealth offer convenient treatment solutions and help expand access.

Regions with concentrated market value

North America dominates the Addiction Treatment Market Regional accounting for the highest share, primarily the US. This can be attributed to the high prevalence of substance abuse disorders in the region along with better reimbursement policies and accessibility to treatment services. The presence of top market players and adoption of innovative therapies also drive the North America addiction treatment market.

Fastest growing region

Asia Pacific is expected to witness the fastest growth during the forecast period owing to growing economic prowess, rising healthcare spending, spreading awareness, and improving infrastructure. Rapid urbanization and changing lifestyle in developing countries lead to increased substance abuse. Moreover, governments are also supporting non-profits and scaling up treatment services to handle the rising problem. This is fueling the growth of addiction treatment market in Asia Pacific region.

Get More Insights on- Addiction Treatment Market

For Deeper Insights, Find the Report in the Language that You want:

About Author:

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)

Comments

Popular posts from this blog

Sustainable Aviation Fuel Market is Set to Witness Significant Growth Due to Stringent Emission Norms

Sustainable Aviation Fuel Market Sustainable aviation fuel, also known as biofuel, refers to jet fuel produced from sustainable feedstocks such as grease, vegetable oils and animal fats. It is mandated to reduce the environmental impact of aviation, with a life cycle carbon footprint up to 80% lower than conventional jet fuel. Governments across regions are adopting policies and targets to promote sustainable aviation fuel uptake among airlines. For instance, the EU aims to reach 2 million tons of sustainable fuel per year by 2030. The global sustainable aviation fuel market is estimated to be valued at US$ 2.37 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sustainable aviation fuel are Eisai Co., Ltd., Novartis AG, AbbVie Inc. (Allergan Plc.), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited, Johnson & Johnson Services,...

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at  US$ 2,334.2 Mn in 2024 , and is expected to exhibit a  CAGR of 5.2% , in terms of revenue, over the forecast period  2024-2031  to reach  US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...

The Global Antifoaming Agent Market is poised to Exhibit Strong Growth

Antifoaming Agent Market The antifoaming agent market is fast gaining traction due to increasing industrial usage of chemicals, especially in numerous end-use sectors like pharmaceuticals, pulp & paper, paints & coatings, oil & gas, and food & beverages. Antifoaming agents are chemicals that reduce or suppress the formation of foam in industrial processes. They are widely used as additives to prevent foaming issues in various industrial applications. Commonly used antifoaming agents include silicone-based, oil-based, and water-based defoamers. These agents find usage in processes involving agitation to prevent excessive foaming that can negatively impact manufacturing operations and product quality. The Global Antifoaming Agent Market is estimated to be valued at US$ 6.08 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Antifoaming Agent market are BASF, Evonik Industries, Air P...